Is Kamini becoming an endemic within the migrant Indian community in Australia?

Abeysundera, Hesitha; Singh, Sohni

doi:10.1177/0004867419864430

Cited by 8 publications

(8 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, the cohort consists only of men (ranging in age from 28 to 41 years), likely reflecting its usage as an aphrodisiac. This is reflected in other published cases [1, 7, 8, 11]. Six out of 12 men had no previous substance use history.…”

Section: Discussionmentioning

confidence: 53%

“…Once thought to be a problem within the expatriate Indian community within Australia there are now concerns that Kamini usage is being mirrored within other ethnic groups [6] due to the ease of access and relatively low cost, with a bottle of Kamini costing $100 [2]. The recognition and management of Kamini dependence is relatively straight forward [1,[7][8][9] and treatment conventionally utilises various forms of opioid substitution therapy, though there is limited published literature available on this topic [1,7,9].…”

Section: Introductionmentioning

confidence: 99%

“…Kamini tablets are handmade and of variable size, containing quantities of opium ranging from 2-20 mg per tablet in one study [7] to up to 160 mg per tablet in another study [8], though it is unclear if these studies are comparing tablets of similar size. It was thought that the morphine content contained within Kamini was equivalent to 10% of the opium content [8] and this would give an oral morphine equivalence per tablet ranging between 0.2 and 16 mg. Chemical analysis of tablets revealed opium alkaloids, morphine, codeine, noscapine, papaverine and heavy metals (lead, mercury and arsenic) [9].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapy

Naren

Silkoff

Forsythe

et al. 2022

Drug and Alcohol Review

View full text Add to dashboard Cite

Introduction: A cohort of clients was recognised attending an addiction medicine clinic with similar presentations of opioid dependence from use of a rarely known Ayurvedic medication in a specific ethnic community. This retrospective case series was completed to promote wider recognition and further understanding of dependence on Kamini Vidrawan Ras (Kamini). Methods: A retrospective file audit of the electronic medical record for clients of an addiction medicine outpatient clinic with a history of dependent use of Kamini identified 12 clients meeting inclusion criteria. Results: All 12 clients were male, aged 27-41 years, all but one of north Indian origin, predominantly employed and predominantly (but not exclusively) without significant other substance use history. All 12 clients were treated with opioid substitution therapy.Discussion and Conclusions: This case series highlights an opioid dependence syndrome resulting from use of an Ayurvedic medicine by men from a specific area of India, highlighting a potential adverse effect of traditional medicines in ongoing use by migrant and ethnic populations that have emigrated to Australia.

show abstract

Section: Discussionmentioning

confidence: 53%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapy

Naren

Silkoff

Forsythe

et al. 2022

Drug and Alcohol Review

View full text Add to dashboard Cite

show abstract

“…In Australia, it is imported illegally and typically sold at Indian grocery stores. 1 Anecdotal evidence suggests widespread use among the Indian migrant community. 1 Case reports of Kamini dependence treated with Suboxone® have been published 1,2 ; however, this is the first report of treatment with depot buprenorphine.…”

mentioning

confidence: 99%

“…1 Anecdotal evidence suggests widespread use among the Indian migrant community. 1 Case reports of Kamini dependence treated with Suboxone® have been published 1,2 ; however, this is the first report of treatment with depot buprenorphine. Written informed consent was obtained to publish the case.…”

mentioning

confidence: 99%

The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report

Kwon¹,

Blazey²,

Montebello³

2021

Australas Psychiatry

View full text Add to dashboard Cite

Fentanyl's potential impact on public health in India and China: A comparative review

Lassi

2024

J of Intl Development

View full text Add to dashboard Cite

This study reviewed and compared fentanyl's potential impact on public health in India and China, two nations linked to its production and distribution. A comparison of China and India's governance structures, historical experiences with opioids, ideologies, and drug policies on the potential for domestic fentanyl use showed that fentanyl will likely become a more significant threat to Indian society. India's relatively weak governance, historical acceptance of opium, and permissive drug culture facilitate an environment conducive to the production and use of fentanyl. In contrast, China's strong central government, the Opium Wars, the historical effects of opium addiction, and adherence to conservative Confucian ethics will likely contribute to opposition to fentanyl use. Understanding these disparities is paramount for policymakers and public health officials in both nations to develop and customise strategies to confront the challenges posed by fentanyl.

show abstract

Is Kamini becoming an endemic within the migrant Indian community in Australia?

Cited by 8 publications

References 2 publications

Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapy

Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapy

The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report

Fentanyl's potential impact on public health in India and China: A comparative review

Contact Info

Product

Resources

About